Cyprus IP Box Nexus Fraction: A Step-by-Step Worked Example (2026)

What is the nexus fraction and why does it exist?

The Cyprus IP Box follows the OECD's Modified Nexus Approach, agreed under BEPS Action 5. The principle is simple: a company should only enjoy the preferential IP rate to the extent it actually performed the research and development (R&D) that created the intangible. You cannot simply buy in a patent or outsource all development to a related party and still claim the full benefit.

The nexus fraction is the mechanism that enforces this. It scales the headline 80% deduction down in proportion to how much qualifying R&D the Cyprus company itself carried out. A company that does all its own R&D gets close to the full benefit; a company that acquired the IP or sub-contracted development to connected parties gets less.

The result is that the headline 'up to 80% deduction' and the often-quoted '~3% effective rate' are best-case figures. The actual benefit depends entirely on your nexus fraction.

The four building blocks of the calculation

Before the worked example, it helps to define the four inputs the regime uses. Getting these definitions right is most of the battle.

• Qualifying expenditure (QE): R&D costs incurred by the Cyprus company itself, plus R&D out-sourced to unrelated third parties. This is the 'good' expenditure that builds nexus.
• Overall expenditure (OE): QE plus the cost of acquiring the IP and any R&D out-sourced to related (connected) parties. This is the full development cost denominator.
• Uplift: a notional increase to QE of up to 30% of QE, capped so it can never push the fraction above 1. It softens the penalty for acquisition costs and related-party R&D.
• Overall income (OI): the income derived from the qualifying intangible asset — typically royalties, embedded IP income in product sales, or licence fees — net of directly attributable expenses.

This is general information, not tax or legal advice. Qualifying-asset and qualifying-expenditure definitions are technical; confirm your specific position with a qualified Cyprus adviser.

How is the nexus fraction calculated?

The nexus fraction is expressed as a formula. Qualifying expenditure is increased by the uplift, then divided by overall expenditure:

Nexus fraction = (Qualifying expenditure + Uplift) ÷ Overall expenditure

The uplift equals the lower of (a) 30% of qualifying expenditure, or (b) the amount of acquisition costs plus related-party out-sourcing. The fraction itself is capped at 1 (100%) — it can never exceed 100% even if the uplift would otherwise take it higher.

Qualifying profit — the amount eligible for the 80% deduction — is then: Overall income × Nexus fraction.

Worked example: a Cyprus SaaS company

Assume CyproSoft Ltd, a Cyprus tax-resident company, owns the qualifying intangible behind its SaaS platform. In the year it earns overall income of €1,000,000 from the qualifying IP (after deducting directly attributable expenses such as hosting, support staff and amortisation).

Its development costs over the relevant tracking period are: €700,000 of in-house R&D (its own Cyprus developers), €100,000 paid to an unrelated third-party agency, €150,000 paid to a related group company for development, and €50,000 to acquire a pre-existing software module from a third party.

Applying the 30% uplift cap

The uplift is the lower of 30% of QE or the total non-qualifying spend (acquisition + related-party R&D).

30% of QE = 30% × €800,000 = €240,000. Non-qualifying spend = €150,000 + €50,000 = €200,000. The uplift is the lower of the two: €200,000.

Note how the cap bites. Even though 30% of QE would allow €240,000, the company only had €200,000 of non-qualifying costs to 'cover', so the uplift is limited to €200,000. The uplift can never exceed the non-qualifying expenditure it is designed to offset.

Computing the nexus fraction and qualifying profit

Now combine the inputs. QE + uplift = €800,000 + €200,000 = €1,000,000. Overall expenditure = €1,000,000.

Nexus fraction = €1,000,000 ÷ €1,000,000 = 1.00 (100%), capped at 1. In this example the uplift is exactly enough to bring the fraction to the cap, so the company achieves the maximum benefit despite having €200,000 of non-qualifying cost.

Qualifying profit = Overall income × nexus fraction = €1,000,000 × 1.00 = €1,000,000.

How the 80% deduction gives ~3% effective

The IP Box allows 80% of qualifying profit to be deducted from the taxable base. With qualifying profit of €1,000,000, the deduction is €800,000, leaving €200,000 of taxable IP profit. That €200,000 is taxed at the standard 15% CIT rate, producing tax of €30,000.

Express that as a percentage of the original €1,000,000 of IP income: €30,000 ÷ €1,000,000 = 3.0%. This is the origin of the widely-quoted ~3% effective rate (20% of profit × 15% CIT = 3%).

What happens when nexus is below 100%?

The ~3% figure assumes a full nexus fraction. To see the penalty for poor nexus, change one fact: suppose CyproSoft did far more of its development through a related group company — say €500,000 related-party R&D and only €300,000 of in-house plus unrelated R&D, with the same €50,000 acquisition.

QE = €300,000. Non-qualifying = €550,000. Uplift = lower of (30% × €300,000 = €90,000) and €550,000 = €90,000. QE + uplift = €390,000. OE = €850,000. Nexus fraction = €390,000 ÷ €850,000 ≈ 0.459.

Qualifying profit = €1,000,000 × 0.459 = €459,000. The 80% deduction = €367,200, leaving €91,800 taxed at 15% = €13,770 from the IP Box stream. The remaining €541,000 of IP income falls outside the qualifying profit and is taxed at the normal 15% = €81,150. Total tax ≈ €94,920, an effective rate of about 9.5% on the €1,000,000 — far from 3%.

This is general information, not tax or legal advice. Figures are illustrative; your nexus fraction depends on your actual expenditure records and the qualifying status of each asset.

Documentation you must keep

Because the regime is expenditure-tracked, record-keeping is not optional. You must be able to demonstrate, per qualifying asset, the link between R&D expenditure and the income it generates.

• A clear identification of each qualifying intangible asset and its qualifying status.
• Expenditure tracking that separates in-house R&D, unrelated out-sourcing, related-party out-sourcing and acquisition costs — ideally on a per-asset basis.
• Income tracking that ties overall income to each qualifying asset.
• Evidence of genuine R&D substance in Cyprus: qualified staff, premises and decision-making.
• Annual recalculation, as the nexus fraction can move year to year as cumulative expenditure changes.

Frequently Asked Questions

Share this article

Disclaimer: This article is for informational purposes only and does not constitute legal, tax, or financial advice. Tax laws change frequently. Consult a qualified Cyprus adviser for guidance specific to your situation. The information on this page is general guidance only and does not constitute legal, tax, accounting, immigration or financial advice. Specific advice should be obtained based on the facts of each case.